摘要
Biomaterials are currently and will continue to exert a high impact in the field of medicine and biological systems.Despite their great importance to humans,biomaterials have been reported to increase the risk of various kinds of cancers.Herein we shed light on the impact of biomaterial on the accumulation of genetic and epigenetic alterations that may boost cancer risk.In addition,we identify the key elements for the selection of the most reconcilable biomaterials and tests to ensure their biocompatibility.We examined the downsides of the usage of these biomaterials;specifically,immunological foreign body response due to wear and corrosion and their ability to cause cancers.The main focus of our review is to highlight the current knowledge about how orthopedic implants may contribute to cancer formation.We conclude that,although the risk appears to be minimal,implants may contribute to the development of cancer demanding the employment of a test that gauges the mutagenicity of the biomaterial used in the various implants’applications.
